Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

A Leopard without Spots: Clinical Diagnosis and Treatment of Rocky Mountain Spotted Fever

Image of Continuing Education Credits abbreviation.= Free Continuing Education

Date: Thursday, April 12, 2018

Time: 2:00pm (Eastern Time)

 

Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for WC2922-041218 – (Webcast) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – A Leopard without Spots: Clinical Diagnosis and Treatment of Rocky Mountain Spotted Fever – April 12, 2018,  please visit TCEO and follow these 9 Simple Steps by May 14, 2018.

To receive continuing education (CE) for WD2922-041218 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – A Leopard without Spots: Clinical Diagnosis and Treatment of Rocky Mountain Spotted Fever – April 12, 2018 (Web on Demand), please visit TCEO and follow these 9 Simple Steps by May 15, 2020.

Overview

Rocky Mountain spotted fever (RMSF), a life-threatening and rapidly progressive tickborne disease, is caused by infection from the bacterium Rickettsia rickettsii. Infection begins with non-specific symptoms like fever, headache, and muscle pain, but unmitigated damage to the vascular endothelium quickly results in organ failure, necrosis, and ultimately death. Early clinical diagnosis is key—as treatment within the first 5 days of illness has been associated with lower mortality. Additionally, newer diagnostics are now available that can aid in early detection. RMSF is a recently-emerging pathogen in Arizona and along the U.S.-Mexico border region. Case fatality rates in these regions have been extremely high and closely tied to widespread tick and free-roaming dog populations. During this COCA call, clinicians will learn about the detection, diagnosis, and epidemiology of RMSF.

At the conclusion of the session, the participant will be able to accomplish the following:

  • Discuss clinical characteristics associated with early, intermediate, and late presentations of RMSF, and those associated with higher risk of fatal outcome.
  • Describe available diagnostic tests for RMSF, advantages and disadvantages of each, and the appropriate time points and specimens for collection.
  • Explain the epidemiology of RMSF in Arizona and along the U.S.-Mexico border, and describe how it differs from other regions in the United States.

Call Slides: View Now
Webinar: Watch Now

Paige Armstrong, MD, MHS
Medical Epidemiologist
National Center for Emerging & Zoonotic Infectious Diseases
Division of Vector-borne Diseases
Centers for Disease Control and Prevention

Naomi Drexler, MPH
Epidemiologist
National Center for Emerging & Zoonotic Infectious Diseases
Division of Vector-borne Diseases
Centers for Disease Control and Prevention

  • Webinar/Audio conference call on 4/12/2018: 2:00 – 3:00 PM ET
  • Web-on-demand training after 3:00 PM ET on 4/12/2018
  • Materials: PowerPoint slide set

Continuing Education

“WC2922” for attendees who participate in the live call (must be completed by May 14, 2018)

“WD2922” for attendees who participate in the online presentation (must be completed by May 15, 2020)

Target Audience

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians

Hardware/Software

Additional Information

  • Contact Information:coca@cdc.gov
  • Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
  • Method of Participation:You may participate in the educational activity by viewing the program information above.
  • Fees:COCA continuing education credits are free.

Accreditation Statements

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

Image of acpe logo.CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-18-127-L04-P and enduring 0387-0000-18-127-H04-P course category.

This activity has been designated as Knowledge-Based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

For Certified Public Health Professionals (CPH)

The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

TOP